Patent Assignment
Reel/Frame 058893/0132
Assignment of Assignor's Interest
Recorded: 2022-02-04
Pages: 3
Assignors
TIAN, WENZHI
Executed: 2022-01-11
LI, SONG
Executed: 2022-01-11
CHEN, DIANZE
Executed: 2022-01-11
Assignee
IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) CO., LTD.
BUILDING #15, LANE 1000, ZHANGHENG ROAD, PUDONG NEW DISTRICT, SHANGHAI, 201203, CHINA
Covered Property
(1)
Recombinant Fusion Proteins Targeting CD47 and CD38, Preparation and Use Thereof
Application:
17/592,976 →
Publication:
US 2023/0110702
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.